Pediatric Immunotherapy Science
Clinical studies referenced below are intended to provide information to medical professionals about allergy immunotherapy. These studies have not been reviewed by the FDA.
SLIT in Children
1.
Specific sublingual immunotherapy (SLIT) in children with perennial rhinitis: a systematic review and meta-analysis.
2.
Mite-Induced Perennial Allergic Rhinitis in Pediatric Patients and Sublingual Immunotherapy.
SLIT vs. SCIT:
1.
Sublingual or subcutaneous immunotherapy for allergic rhinitis?
2.
Sublingual Versus Subcutaneous Immunotherapy for Allergic Rhinitis: What Are the Important Therapeutic and Real-World Considerations?
3.
Subcutaneous and sublingual allergen-specific immunotherapy: a tale of two routes.
4.
New approaches to allergen immunotherapy.
5.
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.
6.
Real world effectiveness of Sublingual Allergen Immunotherapy on the onset and worsening of allergic asthma.
SLIT History
1.
30 years of sublingual immunotherapy.
2.
Sublingual immunotherapy in the United States: history and current relevance in the time of COVID-19.
SLIT Efficacy
1.
Sublingual immunotherapy: current concepts for the U.S. practitioner.
2.
Randomized, double-blind, placebo-controlled trial of standardized ragweed sublingual-liquid immunotherapy for allergic rhinoconjunctivitis.
3.
Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.
4.
Sublingual immunotherapy: World Allergy Organization position paper 2013 update.
SLIT Time to Efficacy
1.
Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
2.
Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults.
SLIT Safety
1.
Allergen Immunotherapy in children with respiratory allergic diseases.
2.
Safety of sublingual-swallow immunotherapy in children and adults.
3.
Safety of sublingual immunotherapy with monomeric allergoid in adults: multicenter post-marketing surveillance study.
4.
Current Evidence on Safety and Practical Considerations for Administration of Sublingual Allergen Immunotherapy (SLIT) in the United States
5.
Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.
SLIT Duration
1.
Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study.
2.
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial.
Compounding and Off-label Prescribing in the U.S.
1.
Understanding differences in allergen immunotherapy products and practices in North America and Europe.
2.
Off-label prescribing. Legal implications.
3.
Off-label Justified or Not?
